or
forgot password

    • cancer clinical trials in south carolina

    • S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    CCOP - Upstate Carolina

    Trial Locations
    CCOP - Upstate Carolina
    Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
    Breast Cancer, Metastatic Cancer
    Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Lymphangioleiomyomatosis
    Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Cancer Centers of the Carolinas - Easley

    Trial Locations
    Cancer Centers of the Carolinas - Easley
    CCOP - Greenville
    Bon Secours St. Francis Health System
    Greenville Hospital Cancer Center
    Cancer Centers of the Carolinas - Grove Commons
    Cancer Centers of the Carolinas - Faris Road
    Self Regional Cancer Center at Self Regional Medical Center
    Cancer Centers of the Carolinas - Greer Medical Oncology
    Cancer Centers of the Carolinas - Seneca
    Cancer Centers of the Carolinas - Spartanburg
    Prostate Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    AnMed Cancer Center

    Trial Locations
    AnMed Cancer Center
    Roper St. Francis Cancer Center at Roper Hospital
    CCOP - Greenville
    Bon Secours St. Francis Health System
    CCOP - Upstate Carolina
    Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Roper Hospital

    Trial Locations
    Roper Hospital
    McLeod Regional Medical Center
    Spartanburg Regional Medical Center
    Upstate Carolina CCOP
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Lung Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    AnMed Cancer Center

    Trial Locations
    AnMed Cancer Center
    Cancer Centers of the Carolinas - Easley
    CCOP - Greenville
    Bon Secours St. Francis Health System
    Greenville Hospital Cancer Center
    Cancer Centers of the Carolinas - Grove Commons
    Cancer Centers of the Carolinas - Faris Road
    Cancer Centers of the Carolinas - Eastside
    Self Regional Cancer Center at Self Regional Medical Center
    Cancer Centers of the Carolinas - Greer Medical Oncology
    Cancer Centers of the Carolinas - Greer Radiation Oncology
    Cancer Centers of the Carolinas - Seneca
    CCOP - Upstate Carolina
    Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
    Cancer Centers of the Carolinas - Spartanburg
    Lung Cancer
    Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Charleston, South Carolina
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
    Institute of Translational Oncology Research
    Greenville, South Carolina 29605
    Small Cell Lung Cancer, Non-small Cell Lung Cancer
    High-dose Bevacizumab in Advanced Renal Carcinoma Patients
    Spartanburg Regional Medical Center
    Spartanburg, South Carolina 29303
    Renal Cancer, Kidney Cancer
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Hollings Cancer Center at Medical University of South Carolina

    Trial Locations
    Hollings Cancer Center at Medical University of South Carolina
    Palmetto Health South Carolina Cancer Center
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    CCOP - Upstate Carolina
    Spartanburg, South Carolina 29303
    Neurotoxicity, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    Cancer Centers of the Carolinas CC of C -Eastside
    Greenville, South Carolina 29605
    Myelogenous Leukemia, Chronic
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    National Allergy, Asthma & Urticaria Centers of Charleston, PA

    Trial Locations
    National Allergy, Asthma & Urticaria Centers of Charleston, PA
    Dermatology and Laser Center of Charleston
    Cheraw Pediatrics, P.A.
    McClerklin Skin and Laser Center
    Dermatology Group LLC
    Allergic Disease & Asthma Center
    Palmetto Skin & Laser Center
    Atopic Dermatitis
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Roper St. Francis Cancer Center at Roper Hospital

    Trial Locations
    Roper St. Francis Cancer Center at Roper Hospital
    McLeod Regional Medical Center
    CCOP - Greenville
    Bon Secours St. Francis Health System
    Greenville Hospital Cancer Center
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific